recMAGE-A3 ASCI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recMAGE-A3 ASCI, covering 2015-02-04 to 2015-02-04. Get the full timeline:
Most recent: Clinical Trial Update: BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients [Phase 1]